IP Library Granted Patent US 11,017,532
Granted Patent B1
US 11,017,532 · App. 16/857,079 · Granted May 25, 2021

Systems and methods for training a model to predict survival time for a patient

Inventors: Andrew H. Beck (Brookline, MA); Aditya Khosla (Watertown, MA)
Assignee: PathAI, Inc.
G06T7/0014G06F16/5866G06K9/6256G06K9/6265G06N5/046G06T7/194G16H10/20G16H50/20G16H50/50G06T2207/20081G06T2207/30004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,017,532
App. No.
16/857,079
Filed
Apr 23, 2020
Granted
May 25, 2021
Kind
B1
Art Unit
2649
USPC
382/128
Abstract

In some aspects, the described systems and methods provide for a method for training a model to predict survival time for a patient. The method includes accessing annotated pathology images associated with a first group of patients in a clinical trial. Each of the annotated pathology images is associated with survival data for a respective patient. Each of the annotated pathology images includes an annotation describing a tissue characteristic category for a portion of the image. Values for one or more features are extracted from each of the annotated pathology images. A model is trained based on the survival data and the extracted values for the features. The trained model is stored on a storage device.

Claims (55)

1. A method for training one or more models to predict survival time for a patient, the method comprising:

accessing a plurality of annotated pathology images associated with a group of patients in a randomized controlled clinical trial, wherein each of the plurality of annotated pathology images is associated with survival data for a respective patient, wherein each of the plurality of annotated pathology images includes at least one annotation describing a tissue characteristic category for a portion of the image, wherein the plurality of annotated pathology images includes:

a first plurality of annotated pathology images associated with a first group of patients belonging to a first treatment group of the randomized controlled clinical trial, and

a second plurality of annotated pathology images associated with a second group of patients belonging to a second treatment group of the randomized controlled clinical trial;

training one or more models based on the survival data and the plurality of annotated pathology images, wherein the one or more trained models include a first plurality of features based in part on the first plurality of annotated pathology images and a second plurality of features based in part on the second plurality of annotated pathology images; and

storing the one or more trained models on at least one storage device.

2. The method of claim 1 , further comprising:

processing, using the one or more trained models, at least the first plurality of features to predict survival data for patients in the first group of patients; and

processing, using the one or more trained models, at least the second plurality of features to predict survival data for patients in the second group of patients.

3. The method of claim 2 , further comprising:

determining a first prognostic performance of the one or more trained models for the first treatment group based on the predicted survival data for the patients in the first group of patients and respective survival data; and

determining a second prognostic performance of the one or more trained models for the second treatment group based on the predicted survival data for the patients in the second group of patients and respective survival data.

4. The method of claim 3 , further comprising:

determining a specificity of a prognostic power of the one or more trained models by comparing the first prognostic performance of the one or more trained models for the first treatment group and the second prognostic performance of the one or more trained models for the second treatment group, wherein the specificity of the prognostic power of the one or more trained models includes a likelihood that the one or more trained models will correctly identify a subset of patients that respond to a particular treatment.

5. The method of claim 4 , wherein comparing the first prognostic performance and the second prognostic performance includes performing subset survival analyses using respective predicted survival data from the first treatment group and the second treatment group.

6. The method of claim 2 , further comprising:

selecting, based on the predicted survival data for the patients in the first group of patients, a subset of the first group of patients that responded to treatment.

7. The method of claim 1 , further comprising:

processing, using the one or more trained models, at least a third plurality of features based in part on a third plurality of annotated pathology images associated with a third group of patients belonging to a third treatment group of the randomized controlled clinical trial or a different randomized controlled clinical trial, to predict survival data for patients in the third group of patients; and

selecting a subset of the third group of patients that are expected to respond to treatment.

8. The method of claim 1 , wherein the first plurality of features and/or the second plurality of features are selected from a group consisting of area of epithelium, area of stroma, area of necrosis, area of cancer cells, area of macrophages, area of lymphocytes, number of mitotic figures, average nuclear grade, average distance between fibroblasts and lymphocytes, average distance between immunohistochemistry-positive macrophages and cancer cells, standard deviation of nuclear grade, average distance between blood vessels and tumor cells.

9. The method of claim 1 , wherein the one or more trained models include a generalized linear model, a random forest, a support vector machine, and/or a gradient boosted tree.

10. A system for training one or more models to predict survival time for a patient, the system comprising:

at least one computer hardware processor; and

at least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform:

accessing a plurality of annotated pathology images associated with a group of patients in a randomized controlled clinical trial, wherein each of the plurality of annotated pathology images is associated with survival data for a respective patient, wherein each of the plurality of annotated pathology images includes at least one annotation describing a tissue characteristic category for a portion of the image, wherein the plurality of annotated pathology images includes:

a first plurality of annotated pathology images associated with a first group of patients belonging to a first treatment group of the randomized controlled clinical trial, and

a second plurality of annotated pathology images associated with a second group of patients belonging to a second treatment group of the randomized controlled clinical trial;

training one or more models based on the survival data and the plurality of annotated pathology images, wherein the one or more trained models include a first plurality of features based in part on the first plurality of annotated pathology images and a second plurality of features based in part on the second plurality of annotated pathology images; and

storing the one or more trained models on at least one storage device.

11. The system of claim 10 , wherein the processor-executable instructions further cause the at least one computer hardware processor to perform:

processing, using the one or more trained models, at least the first plurality of features to predict survival data for patients in the first group of patients; and

processing, using the one or more trained models, at least the second plurality of features to predict survival data for patients in the second group of patients.

12. The system of claim 11 , wherein the processor-executable instructions further cause the at least one computer hardware processor to perform:

determining a first prognostic performance of the one or more trained models for the first treatment group based on the predicted survival data for the patients in the first group of patients and respective survival data; and

determining a second prognostic performance of the one or more trained models for the second treatment group based on the predicted survival data for the patients in the second group of patients and respective survival data.

13. The system of claim 12 , wherein the processor-executable instructions further cause the at least one computer hardware processor to perform:

determining a specificity of a prognostic power of the one or more trained models by comparing the first prognostic performance of the one or more trained models for the first treatment group and the second prognostic performance of the one or more trained models for the second treatment group, wherein the specificity of the prognostic power of the one or more trained models includes a likelihood that the one or more trained models will correctly identify a subset of patients that respond to a particular treatment.

14. The system of claim 13 , wherein comparing the first prognostic performance and the second prognostic performance includes performing subset survival analyses using respective predicted survival data from the first treatment group and the second treatment group.

15. The system of claim 11 , wherein the processor-executable instructions further cause the at least one computer hardware processor to perform:

selecting, based on the predicted survival data for the patients in the first group of patients, a subset of the first group of patients that responded to treatment.

16. The system of claim 10 , wherein the processor-executable instructions further cause the at least one computer hardware processor to perform:

processing, using the one or more trained models, at least a third plurality of features based in part on a third plurality of annotated pathology images associated with a third group of patients belonging to a third treatment group of the randomized controlled clinical trial or a different randomized controlled clinical trial, to predict survival data for patients in the third group of patients; and

selecting a subset of the third group of patients that are expected to respond to treatment.

17. The system of claim 10 , wherein the first plurality of features and/or the second plurality of features are selected from a group consisting of area of epithelium, area of stroma, area of necrosis, area of cancer cells, area of macrophages, area of lymphocytes, number of mitotic figures, average nuclear grade, average distance between fibroblasts and lymphocytes, average distance between immunohistochemistry-positive macrophages and cancer cells, standard deviation of nuclear grade, average distance between blood vessels and tumor cells.

18. The system of claim 10 , wherein the one or more trained models include a generalized linear model, a random forest, a support vector machine, and/or a gradient boosted tree.

19. A non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by at least one computer hardware processor, cause the at least one computer hardware processor to perform:

accessing a plurality of annotated pathology images associated with a group of patients in a randomized controlled clinical trial, wherein each of the plurality of annotated pathology images is associated with survival data for a respective patient, wherein each of the plurality of annotated pathology images includes at least one annotation describing a tissue characteristic category for a portion of the image, wherein the plurality of annotated pathology images includes:

a first plurality of annotated pathology images associated with a first group of patients belonging to a first treatment group of the randomized controlled clinical trial, and

a second plurality of annotated pathology images associated with a second group of patients belonging to a second treatment group of the randomized controlled clinical trial;

training one or more models based on the survival data and the plurality of annotated pathology images, wherein the one or more trained models include a first plurality of features based in part on the first plurality of annotated pathology images and a second plurality of features based in part on the second plurality of annotated pathology images; and

storing the one or more trained models on at least one storage device.

20. The non-transitory computer-readable storage medium of claim 19 , wherein the processor-executable instructions further cause the at least one computer hardware processor to perform:

processing, using the one or more trained models, at least the first plurality of features to predict survival data for patients in the first group of patients; and

processing, using the one or more trained models, at least the second plurality of features to predict survival data for patients in the second group of patients.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jul 28, 2026
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT
To: PATHAI, INC.
Reel/Frame 075427/0613 →
SECURITY INTEREST Recorded Sep 22, 2025
From: PATHAI, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT FOR SECURED PARTIES
Reel/Frame 072322/0631 →
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: PATHAI, INC.
Reel/Frame 072300/0731 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT AT R/F 059450/0397 Recorded Dec 29, 2022
From: JPMORGAN CHASE BANK, N.A
To: PATHAI, INC.
Reel/Frame 062250/0085 →
SECURITY INTEREST Recorded Dec 23, 2022
From: PATHAI, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 062195/0001 →
SECURITY INTEREST Recorded Mar 30, 2022
From: PATHAI, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 059450/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: KHOSLA, ADITYA; BECK, ANDREW H.
To: PATHAI, INC.
Reel/Frame 053264/0714 →
Continuity (4)
Continuation 16001836 · Jun 6, 2018
Provisional Application 62515772 · Jun 6, 2017
Provisional Application 62515779 · Jun 6, 2017
Provisional Application 62515795 · Jun 6, 2017
Cited By (3)
US 12,580,081 US 12,597,523 US 12,683,031